Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
260.00    0.00 (0.00%)
Bid:
252.00
Ask:
257.00
Spread: 5.00 (1.984%)
Market Cap: £232.84m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Interim Management Statement

13 May 2014 07:00

RNS Number : 8996G
Wilmington Group Plc
13 May 2014
Β 

ο»Ώ

Β 

13 May 2014

Β 

Wilmington Group plc

Interim Management Statement

Β 

Wilmington Group plc ("Wilmington" or "the Group"), the provider of Information, Compliance and Education to professional markets, announces its Interim Management Statement for the period from 1 January 2014, based on the results for the Group's third quarter trading period to 31 March 2014 with comments reflecting trading to date.

Β 

Trading Update

Β 

As expected, Group revenue during the period from 1 January 2014 to the end of March 2014 is up 5% on the same period last year, reflecting contributions from our recent acquisitions, which were partially offset by some continued rationalisation.

Β 

During the three month period, we have continued to see good growth in underlying operating profits and margins across all the business divisions except, as previously indicated, in our Legal division which continues to face challenging market conditions.

Β 

The Group generates an increasing proportion of its income from overseas markets. The recent strengthening of the pound, in particular against the US dollar, has had a small negative effect on our results when translating foreign currency earnings into sterling.

Β 

Operational Review

Β 

Pensions & Insurance: This division delivered good revenue and contribution growth during the period, especially within the international insurance market and its high margins have been maintained. Inese, the provider of subscriptions based publications, training and events which was acquired in March 2013 has delivered a solid performance including a strong performance from its flagship annual "Insurance Week" congress held in February 2014.

Β 

Banking & Compliance: This division benefited from strong revenue growth during the period. In particular ICT (compliance training) has continued to secure major in-house training assignments from international banks and has a strengthening pipeline of projects into the next financial year. Revenue growth has been particularly strong in recent weeks. The integration of Compliance Week, a provider of subscription based publications, events and online services which was acquired in August 2013, continues as planned with strong sales for the flagship annual event "Compliance Week Annual Conference" to be held in Washington DC May 2014.

Β 

Healthcare: The strong performance reported by APM in France during 2013 has continued.Binley's revenues recovered slightly in the quarter after being under pressure, and overall underlying contribution from the division increased slightly. The integration of NHiS, a provider of business intelligence, data analysis, workflow tools and other services to pharmaceutical companies, which was combined with the smaller equivalent Binley's operation has progressed well but revenue growth has been weaker than expected in the quarter. We have recently strengthened our senior management team to support the new combined information and services offerings to our pharmaceutical client base.

Β 

Legal: The Legal division continues to show a decline in turnover, reflecting the further scaling back of some course programmes as demand for CPD courses remains weak. However, this revenue decline is partly offset by the flexible cost base and the continued strong performance from Bond Solon. We have carried out some further rationalisation and have appointed a new Managing Director to head up the division.

Β 

Business Intelligence: As anticipated, revenue is down on the same period in the prior year, reflecting discontinued activities as a result of planned disposals and the expected decline in legacy publishing as we continue to transition from print to digital. However, contribution from this division in this quarter is in line with expectations and up slightly on prior year.

Β 

Accountancy: The division had a good third quarter driven by a strong demand for marketing and support services around the UK Government's annual fiscal budget.

Β 

Cash flow

Β 

The Group's cash position remains robust. Net debt as at 31 March 2014 was Β£34.6m (31 March 2013 Β£35.3m) despite recent spending on acquisitions including the acquisition of Compliance Week for Β£7.2m in August 2013, illustrating the Group's continued strong cash generation.

Β 

Outlook

Β 

The overall trading background has not changed significantly since the 2013/14 Interim Results announcement. The Group continues to invest in new technology and new product development and the larger businesses; Banking & Compliance and Pensions & Insurance, are both performing well with each enjoying strong organic growth. Market conditions remain weak for our Legal division, but we have taken action to address margins. Overall, the Group's financial performance is in line with the Board's expectations and Wilmington is on track to support expectations for the full year.

Β 

-End-

Β 

Β 

For further information, please contact:

Β 

Wilmington Group Plc

Charles Brady, Chief Executive

Tony Foye, Finance Director

Β 

FTI Consulting

Charles PalmerΒ 

Β 

020 7422 6800

Β 

Β 

Β 

020 7831 3113

Β 

Β 

Notes to Editors

Β 

Wilmington Group plc is one of the UK's leading providers of Information, Compliance and Education for professional business markets. The Group provides business intelligence, information, training, education, events and support services for a variety of markets including the accountancy, banking, charities, financial services, healthcare, insurance, legal, and pensions sectors. Capitalised at approximately Β£200 million, Wilmington floated on the London Stock Exchange in 1995.

Β 

Β 

Β 

Β 

Β 

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
IMSGGUWGAUPCGQP
Date   Source Headline
14th Aug 20201:38 pmRNSHolding(s) in Company
15th Jul 20202:08 pmRNSHolding(s) in Company
3rd Jul 20204:36 pmRNSPrice Monitoring Extension
2nd Jul 20206:30 pmRNSHolding(s) in Company
2nd Jul 20206:28 pmRNSHolding(s) in Company
2nd Jul 20206:23 pmRNSHolding(s) in Company
25th Jun 20207:00 amRNSPre-close Trading Update and Banking Arrangements
28th May 202010:18 amRNSHolding(s) in Company
21st May 20204:49 pmRNSHolding(s) in Company
20th May 20204:40 pmRNSSecond Price Monitoring Extn
20th May 20204:35 pmRNSPrice Monitoring Extension
13th May 20201:47 pmRNSHolding(s) in Company
2nd Apr 20207:00 amRNSEmployee Share Ownership Trust Purchase
27th Mar 202011:14 amRNSDirector/PDMR Shareholding
26th Mar 20204:18 pmRNSDirector/PDMR Shareholding
25th Mar 20207:00 amRNSUpdate on COVID-19 Coronavirus Impact and Dividend
9th Mar 202010:02 amRNSEmployee Share Ownership Trust Purchase
9th Mar 20207:00 amRNSUpdate on COVID-19 Coronavirus
3rd Mar 20208:51 amRNSTotal Voting Rights
24th Feb 20204:41 pmRNSSecond Price Monitoring Extn
24th Feb 20204:36 pmRNSPrice Monitoring Extension
20th Feb 20207:00 amRNSDirectorate Change
20th Feb 20207:00 amRNSDirectorate Change
20th Feb 20207:00 amRNSHalf-year Report
20th Feb 20207:00 amRNSHalf-year Report
13th Feb 20202:22 pmRNSEmployee Share Ownership Trust Purchase
9th Jan 20209:20 amRNSEmployee Share Ownership Trust Purchase
2nd Jan 20209:02 amRNSTotal Voting Rights
19th Dec 201910:35 amRNSEmployee Share Ownership Trust Purchase
16th Dec 20193:19 pmRNSHolding(s) in Company
6th Dec 20193:16 pmRNSHolding(s) in Company
3rd Dec 20192:40 pmRNSEmployee Share Ownership Trust Purchase
2nd Dec 201910:44 amRNSTotal Voting Rights
2nd Dec 20199:07 amRNSEmployee Share Ownership Trust Purchase
25th Nov 201910:49 amRNSHolding(s) in Company
5th Nov 201912:57 pmRNSResult of AGM
5th Nov 20197:00 amRNSAGM Statement and Q1 Trading Update
1st Nov 20197:00 amRNSTotal Voting Rights
31st Oct 20194:35 pmRNSPrice Monitoring Extension
3rd Oct 20193:48 pmRNSDirector/PDMR Shareholding
1st Oct 20193:06 pmRNSDirector/PDMR Shareholding
1st Oct 20197:00 amRNSVoting Rights and Capital
20th Sep 20193:05 pmRNSDirector/PDMR Shareholding
19th Sep 20191:37 pmRNSREPLACEMENT: Share Awards
19th Sep 201911:59 amRNSShare Awards
19th Sep 20197:00 amRNSFinancial results for the year ended 30 June 2019
2nd Sep 201910:51 amRNSVoting Rights and Capital
22nd Aug 20193:03 pmRNSHolding(s) in Company
1st Aug 20197:00 amRNSTotal Voting Rights
9th Jul 20194:49 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.